Scientific paper - Review paper
The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients
Rheumatology International, 37 (2017), 12; 2105-2114. https://doi.org/10.1007/s00296-017-3843-x

Zekić, Tatjana; Stanić Benić, Mirjana; Antulov, Ronald; Antončić, Igor; Novak, Srđan

Cite this document

Zekić, T., Stanić Benić, M., Antulov, R., Antončić, I. & Novak, S. (2017). The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients. Rheumatology International, 37. (12), 2105-2114. doi: 10.1007/s00296-017-3843-x

Zekić, Tatjana, et al. "The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients." Rheumatology International, vol. 37, no. 12, 2017, pp. 2105-2114. https://doi.org/10.1007/s00296-017-3843-x

Zekić, Tatjana, Mirjana Stanić Benić, Ronald Antulov, Igor Antončić and Srđan Novak. "The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients." Rheumatology International 37, no. 12 (2017): 2105-2114. https://doi.org/10.1007/s00296-017-3843-x

Zekić, T., et al. (2017) 'The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients', Rheumatology International, 37(12), pp. 2105-2114. doi: 10.1007/s00296-017-3843-x

Zekić T, Stanić Benić M, Antulov R, Antončić I, Novak S. The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients. Rheumatology International [Internet]. 2017 [cited 2024 June 22];37(12):2105-2114. doi: 10.1007/s00296-017-3843-x

T. Zekić, M. Stanić Benić, R. Antulov, I. Antončić and S. Novak, "The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients", Rheumatology International, vol. 37, no. 12, pp. 2105-2114, 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:137940. [Accessed: 22 June 2024]